STTK insider buying and SEC filings, explained
Shattuck Labs, Inc. · CIK 1680367
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$592K
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Jul 2, 2026 | Planned (10b5-1) | Abhinav A. Shukla (Chief Technical Officer) sold 410 shares at about $7.01 ($3K), marked as a 10b5-1 plan trade. Holdings down <1% to 86,380 shares. | SEC filing Filed Jul 7, 2026 |
| Jun 30–Jul 1, 2026 | Planned (10b5-1) | Abhinav A. Shukla (Chief Technical Officer) sold 23,465 shares between Jun 30 and Jul 1 at about $7.08 ($166K), marked as a 10b5-1 plan trade. Holdings down 21% to 86,380 shares. | SEC filing Filed Jul 2, 2026 |
| Jun 30, 2026 | Planned (10b5-1) | Arundathy N. Pandite (Chief Medical Officer) sold 30,000 shares at about $7.01 ($210K), marked as a 10b5-1 plan trade. Holdings down 18% to 136,219 shares. | SEC filing Filed Jul 2, 2026 |
| Jun 11, 2026 | Other purchase | Mona Ashiya (Director) bought 1,250,000 shares indirectly; the filing does not report a price. Indirect holdings up 31% to 5,303,908 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 15, 2026 |
| Jun 11, 2026 | Other purchase | ORBIMED ADVISORS LLC (Director) bought 1,250,000 shares indirectly; the filing does not report a price. Indirect holdings up 31% to 5,303,908 shares. Not marked as a 10b5-1 plan trade. Filed jointly with 2 other reporting owners. | SEC filing Filed Jun 15, 2026 |
| Jun 9, 2026 | Other purchase | Clay B. Siegall (Director) bought 62,500 Common Stock at $4.00 ($250K) in a public offering. Holdings up 24% to 318,608 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 11, 2026 |
| May 12, 2026 | Planned (10b5-1) | Abhinav A. Shukla (Chief Technical Officer) sold 2,032 shares at about $7.01 ($14K), marked as a 10b5-1 plan trade. Holdings down 2% to 81,258 shares. | SEC filing Filed May 14, 2026 |
| May 12, 2026 | Planned (10b5-1) | Arundathy N. Pandite (Chief Medical Officer) sold 30,000 shares at about $6.61 ($198K), marked as a 10b5-1 plan trade. Holdings down 15% to 166,219 shares. | SEC filing Filed May 14, 2026 |
27 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow STTK in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.